Maxygen, Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report

iCD Research
February 6, 2012
32 Pages - SKU: ICDR6792219
License type:
Table of Contents Search inside this report Related Reports
Synopsis

ICD Research's Maxygen, Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company.

Summary

ICD Research's Maxygen, Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report is a crucial resource for industry executives and anyone looking to access key information about Maxygen, Inc..

ICD Research's Maxygen, Inc: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Scope
  • Examines and identifies key information and issues about Maxygen, Inc. for business intelligence requirements.
  • Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
  • Provides data on company financial performance.
  • The profile also contains information on business operations, company history, major products and services, prospects, key employees, locations and subsidiaries.
Reasons To Buy
  • Quickly enhance your understanding of Maxygen, Inc. .
  • Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.
  • Increase business/sales activities by understanding your competitors’ businesses better.
  • Recognize potential partnerships and suppliers.
Key Highlights

Maxygen, Inc. (Maxygen) is a biotechnology company focused on developing improved versions of protein-based pharmaceuticals through external collaborations, internal development and other arrangements. The company is developing protein compounds to treat serious diseases, such as neutropenia, or the low white blood cell count often caused by chemotherapy treatments. Maxygen uses MolecularBreeding directed evolution technology platform, ancillary technologies, and extensive protein modification expertise for creating biosuperior proteins. The company carries out its R&D activities through its majority-owned subsidiary, Perseid Therapeutics LLC. Maxygen is headquartered in Redwood City, California, the US.


 

Share this report


Other tasks

 
 

Research Assistance

Ask a question
 

Related Markets


Pharmaceuticals Company Reports

 
 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!